afoxolaner 136 MG Chewable Tablet [NexGard]
Semantic Scholar uses AI to extract papers important to this topic.
Twelve healthy dogs were included in this laboratory efficacy study. Six dogs were randomly allocated based on body weight to an… Expand The efficacy of NexGard® and NexGard Spectra® against sarcoptic mange in dogs was evaluated in a clinical field study. Skin… Expand The efficacy of a monthly oral endectocide product, NexGard Spectra® (Merial), a combination of afoxolaner and milbemycin oxime… Expand A fixed-combination chewable tablet incorporating afoxolaner plus milbemycin oxime (NexGard Spectra®, Merial) was tested in… Expand BackgroundThe efficacy of a single 2.5 mg/kg dose of afoxolaner (NexGard®, Merial) against induced Otodectes cynotis infestations… Expand BackgroundThe ability of the topical spot-on Advantix® (50 % permethrin/10 % imidacloprid) to prevent transmission of Ehrlichia… Expand A randomized, blinded, negative controlled study was conducted to determine whether treatment with afoxolaner (NexGard®, Merial… Expand The nematode Spirocerca lupi (Rudolphi, 1809) is widely distributed but mostly occurs sporadically with stable populations only… Expand Because of their convenience, oral dosage forms are an emerging trend in companion animal formulations.
Ectoparasiticides… Expand BackgroundCanine babesiosis due to Babesia canis is an endemic disease in many European countries. A vaccine is available in some… Expand